Freek R. van ‘t Land1 article listing Freek R. van ‘t Land in Nature Communications, indexed by Paperzzz from Crossref and OSF.REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer Nature Communications